These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1430391)

  • 41. Surgical margins for possibly malignant melanocytic lesions.
    Stigall LE; Zitelli JA
    J Am Acad Dermatol; 2014 Sep; 71(3):588-9. PubMed ID: 25128107
    [No Abstract]   [Full Text] [Related]  

  • 42. Reexcision perineural invasion: a mimic of malignancy.
    Beer TW
    Am J Dermatopathol; 2006 Oct; 28(5):423-5. PubMed ID: 17012918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J; Pressley Z; Veledar E; Washington C; Chen SC
    J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The utility of dermoscopy-guided histologic sectioning for the diagnosis of melanocytic lesions: A case-control study.
    Merkel EA; Amin SM; Lee CY; Rademaker AW; Yazdan P; Martini MC; Guitart J; Gerami P
    J Am Acad Dermatol; 2016 Jun; 74(6):1107-13. PubMed ID: 26826889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reply to 'surgical margins for possibly malignant melanocytic lesions'.
    Comfere NI; Peters MS
    J Am Acad Dermatol; 2014 Sep; 71(3):589-90. PubMed ID: 25128109
    [No Abstract]   [Full Text] [Related]  

  • 46. [Dysplastic nevus].
    Shchetinina LN; Parshiikova SM
    Arkh Patol; 1992; 54(2):45-7. PubMed ID: 1524502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
    Barnhill RL
    Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Margin comments in dermatopathology reports on dysplastic nevi influence re-excision rates.
    Comfere NI; Chakraborty R; Peters MS
    J Am Acad Dermatol; 2013 Nov; 69(5):687-692. PubMed ID: 23932648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").
    Barnhill RL; Argenyi Z; Berwick M; Duray PH; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Paine S; Piepkorn MW; Prieto V; Rabkin MS; Schmidt B; Selim A; Shea CR; Trotter MJ
    Am J Surg Pathol; 2008 Jan; 32(1):36-44. PubMed ID: 18162768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype.
    Piepkorn M; Meyer LJ; Goldgar D; Seuchter SA; Cannon-Albright LA; Skolnick MH; Zone JJ
    J Am Acad Dermatol; 1989 Mar; 20(3):407-15. PubMed ID: 2918113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dysplastic vulvar nevi.
    Blickstein I; Feldberg E; Dgani R; Ben-Hur H; Czernobilsky B
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):968-70. PubMed ID: 1923241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meyerson Phenomenon as a Component of Melanoma in situ.
    Sezer E; Özturk Durmaz E; Çetin E; Şahin S
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):81-2. PubMed ID: 27149137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Large atypical melanocytic nevi in recessive dystrophic epidermolysis bullosa: clinicopathological, ultrastructural, and dermoscopic study.
    Gallardo F; Toll A; Malvehy J; Mascaró-Galy JM; Lloreta J; Barranco C; Pujol RM
    Pediatr Dermatol; 2005; 22(4):338-43. PubMed ID: 16060872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7--challenging the concept of dysplastic nevi as precursor lesions?
    Decarlo K; Yang S; Emley A; Wajapeyee N; Green M; Mahalingam M
    Hum Pathol; 2010 Jun; 41(6):886-94. PubMed ID: 20233623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Digital epiluminescence microscopy monitoring of high-risk patients.
    Robinson JK; Nickoloff BJ
    Arch Dermatol; 2004 Jan; 140(1):49-56. PubMed ID: 14732660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel.
    Weinstock MA; Barnhill RL; Rhodes AR; Brodsky GL
    Arch Dermatol; 1997 Aug; 133(8):953-8. PubMed ID: 9267239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors associated with the prevalence of atypical nevus in a Mediterranean pigmented skin lesion clinic.
    Lasithiotakis KG; Kokolakis A; Giannikaki E; Krasagakis K; Tosca A
    Melanoma Res; 2011 Oct; 21(5):469-73. PubMed ID: 21760555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histologic features seen in changing nevi after therapy with an 810 nm pulsed diode laser for hair removal in patients with dysplastic nevi.
    Soden CE; Smith K; Skelton H
    Int J Dermatol; 2001 Aug; 40(8):500-4. PubMed ID: 11703520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dermoscopy of melanocytic neoplasms: subpatterns of dysplastic/atypical nevi.
    Grichnik JM
    Arch Dermatol; 2003 Dec; 139(12):1696. PubMed ID: 14676098
    [No Abstract]   [Full Text] [Related]  

  • 60. Dysplastic nevi.
    Farber MJ; Heilman ER; Friedman RJ
    Dermatol Clin; 2012 Jul; 30(3):389-404. PubMed ID: 22800547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.